5.19.2016 Approved Phase I/II Clinical Trial for a new type I diabetes therapy

You are here

The Stem Cell Educator therapy system for type I diabetes has been approved by the FDA for phase I/II clinical trials for the treatment of type I diabetes.   This therapy system was initially developed at the University of Illinois - Chicago campus by Dr. Yong Zhao, Dr. Mark Holterman and Dr. Theodore Mazzone.  The therapey involves using stem cells drawn from human umbilical-cord blood to treat a variety of autoimmune diseases, such as psoriasis, alopecia areata, grave's disease, and diabetes.  This technology was first licensed in 2011 to Tianhe Stem Cell Biotechnologies, a startup company, founded by Dr. Yong Zhao.

For more information, please go to Tianhe's press release found here.